Yahoo Web Search

Search results

1. markets.ft.markitdigital.com › data › equitiesAstraZeneca PLC, AZN:LSE summary - FT.com

   markets.ft.markitdigital.com › data › equities

   • Cached

   1 day ago · Latest AstraZeneca PLC (AZN:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

2. Top stories

   • 

     AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines

     On Thursday, AstraZeneca Plc (NASDAQ:AZN) reported second-quarter sales of $12.94 billion, up 13% year over year (+17% at constant currency), beating the consensus of $12.75 ...

     Benzinga via Yahoo

     17 hours ago

   • GuruFocus.com via Yahoo

     Eaton Vance Worldwide Health Sciences Fund's Strategic Moves in Q2 2024: Spotlight on ...

     10 hours ago

   • Benzinga via Yahoo

     Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants

     2 days ago

   • Benzinga via Yahoo

     Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand

     18 hours ago

   • 

     Reuters via Yahoo

     Analysis-Drug giants eye China for deals despite growing Sino-US tensions

     3 days ago

   • Investing.com via Yahoo

     Biden's speech, Ford's miss, European earnings - what's moving markets

     The tech-led selloff looks set to continue Thursday, while Ford has also disappointed with a second-quarter profit miss. President Joe Biden addressed the nation on Wednesday for the first time ...

     1 day ago

   View all

3. uk.finance.yahoo.com › news › astrazeneca-share-price-dipsThe AstraZeneca share price dips as the company raises full-year...

   uk.finance.yahoo.com › news › astrazeneca-share-price-dips

   • Cached

   1 day ago · The AstraZeneca share price dips as the company raises full-year guidance! The majority of City analysts rate AstraZeneca (LSE: AZN) as either a Buy or a Strong Buy, and there may be further long-term gains ahead for the share price. Meanwhile, today’s (25 July) half-year report from the science-led biopharmaceutical company’s encouraging.

4. markets.ft.com › data › equitiesAstraZeneca PLC, AZN:LSE historical prices - FT.com

   markets.ft.com › data › equities

   • Cached

   3 days ago · Latest AstraZeneca PLC (AZN:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

5. simplywall.st › lse-azn › astrazeneca-sharesAstraZeneca (LSE:AZN) - Stock Price, News & Analysis - Simply...

   simplywall.st › lse-azn › astrazeneca-shares

   • Cached

   2 days ago · Research AstraZeneca's (LSE:AZN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

   • 52 Week High: UK£127.04
   • Beta: 0.17

   • 52 Week Low: UK£94.61
   • Current Share Price: UK£123.56

6. www.marketbeat.com › stocks › LONAstraZeneca (AZN) Share Price, Stock Value, News & Analysis -...

   www.marketbeat.com › stocks › LON

   • Cached

   1 day ago · AstraZeneca's stock price has been on an upward trend, with a 50-day moving average price of $77.95, indicating positive market sentiment. Institutional investors have been increasing their holdings in AstraZeneca, reflecting confidence in the company's future growth prospects.

   • 1.3/5
   • Phone: 020 7304 5000

   • Location: 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom
   • Employees: 90K

7. www.reuters.com › business › healthcare-pharmaceuticalsAstraZeneca raises profit outlook on strong medicines demand

   www.reuters.com › business › healthcare-pharmaceuticals

   13 hours ago · Expects 2024 sales and profit to grow by a mid teens percentage Q2 sales of $12.94 billion beat forecast, core EPS $1.98 in line Shares fell as much as 4% July 25 (Reuters) - Anglo-Swedish ...

8. sg.finance.yahoo.com › news › astrazeneca-h1-q2-2024-financialAstraZeneca’s H1 and Q2 2024 Financial Results - Yahoo Finance

   sg.finance.yahoo.com › news › astrazeneca-h1-q2-2024-financial

   • Cached

   1 day ago · KNOXVILLE, Tenn., July 25, 2024 (GLOBE NEWSWIRE) -- SmartFinancial, Inc. (“SmartFinancial”) (NYSE: SMBK), the parent company for SmartBank, announced that on July 25, 2024, the board of directors of SmartFinancial declared a quarterly cash dividend of $0.08 per share of SmartFinancial common stock payable on August 26, 2024, to shareholders of record as of the close of business on August 9 ...